The coronavirus disease 2019 (COVID-19) pandemic has prompted a rapid and unprecedented reorganization of medical institutions, affecting clinical care for patients with chronic neurological diseases. Although there is no evidence that patients with neuromuscular disorders (NMD) confer a higher infection risk of COVID-19, NMD and its associated therapies may affect the patient’s ability to cope with infection or its systemic effects. Moreover, there is a concern that patients with chronic NMD may be at increased risk of manifesting severe symptoms of COVID-19. In particular, as respiratory compromises account for the major cause of mortality and morbidity in NMD patients, newly emerging data also show that the risk of exacerbation caused by COVID-19 accumulates in this particular patient group. For example, patients with motor neuron disease and dystrophinopathies often have ventilatory muscle weakness or cardiomyopathy, which may increase the risk of severe COVID-19 infection. Thus, the COVID-19 pandemic may severely affect NMD patients. Several neurological associations and neuromuscular networks have recently guided the impact of COVID-19 on patients with NMD, especially in managing cardiopulmonary involvements. It is recommended that patients with moderate- to high-risk NMD be sophisticatedly monitored to reduce the risk of rapid decline in cardiopulmonary function or potential deterioration of the underlying NMD. However, limited neuromuscular-specific recommendations for NMD patients who contract COVID-19 and outcome data are lacking. There is an urgent need to properly modify the respiratory care method for NMD patients, especially during the COVID-19 pandemic. Conclusively, COVID-19 is a rapidly evolving field, and the practical guidelines for the management of NMD patients are frequently revised. There must be a close collaboration in a multidisciplinary care team that should support their hospital to define a standardized care method for NMD patients during the COVID pandemic. This article reviews evidence-based practical guidelines regarding care delivery, modification, and education, highlighting the need for team-based and interspecialty collaboration.
【저자키워드】 Telemedicine, COVID- 19, Multidisciplinary care, Respiratory care, neuromuscular disorder, 【초록키워드】 COVID-19, coronavirus disease, pandemic, therapy, Mortality, COVID-19 pandemic, hospital, Infection, Cardiopulmonary, risk, outcome, COVID, Deterioration, systemic effects, management, morbidity, Patient, infection risk, Cardiomyopathy, clinical care, disease, Care, patients, association, Evidence, neurological, Support, Severe COVID-19 Infection, increased risk, ventilatory, respiratory compromise, weakness, disorder, Neurological diseases, Modification, motor neuron, Affect, recommendation, caused, example, the patient, to define, reduce, affecting, accumulate, modify, severe symptom, highlighting, patients with moderate, 【제목키워드】 COVID-19, Neuromuscular,